[Ip-health] (no subject)

German Velasquez gvelasquez.gva at gmail.com
Tue Oct 18 07:10:57 PDT 2016


*Anemic WHO response to the UN Secretary-General High-Level Panel report on
access to medicines.*

According to the minutes of teleconference between WHO Director-General
Margaret Chan and the members of the Executive Board bureau, (distributed
to all WHO Members States on last 28 September) the request from India and
the Member States of the South-East Asia Region, and supported by Brazil,
Iran and South Africa, to include the report of the UN Secretary General
High Level Panel -UN SG HLP- was rejected.

After almost 4 years of a “limbo” in WHO on the substantive elements of the
Global Strategy and plan of Action on public Health, Innovation and
Intellectual Property, WHO risks losing leadership and delay another year
the debate. If the executive board does not discuss in the next month of
January 2017 this important report, means that no discussion could take
place before the World Health Assembly in May 2018.

In a note sent to all member states WHO Secretariat inform that: « The
Director-General and the Officers of the Executive Board met by
teleconference on Wednesday 28 September, in order to review the draft
provisional agenda of the 140th session of the Board to be held in January
2017, in accordance with Rule 8 of the Rules of Procedure of the Executive
Board. Mr Ramjanam Chaudhary (Nepal), Vice-Chairman, and Dr Phusit
Prakongsai (Thailand), Chairman of the Programme, Budget and Administration
Committee of the Executive Board, were unable to attend. »

On the request from India and the Member States of the South-East Asia
Region, and supported by Brazil, Iran and South Africa the « Officers of
the Executive Board agreed the following:

• not to include on the provisional agenda of the 140th session of the
Executive Board the item on “Access to medicines: report of the United
Nations Secretary-General’s High Level Panel on Access to Medicines”, which
had been proposed by the Government of India and supported by the Member
States of the South-East Asia Region. »

For those that still believe in the need for WHO leadership in public
health, it is imperative that the WHO Secretariat expeditiously implements
the recommendations of the Final Report of the UN Secretary-General's
High-Level Panel on Access to Medicines.

German Velasquez

Former Director of WHO Secretariat on Public Health Innovation and
Intellectual Property



More information about the Ip-health mailing list